WAUKESHA, Wis.--(BUSINESS WIRE)--GE Healthcare (NYSE:GE) and Veran, a provider of proprietary 4D registration capability for precise targeting of lesions via its FDA cleared platform, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback